The biological activity of the multifunctional cytokine interleukin-1 (IL-1) is mediated by its receptors. The aim of this study was to determine if an association exists between single nucleotide polymorphisms (SNPs) in the IL-1 type 1 and 2 receptor genes (IL1R1 and IL1R2) and the expression level of membrane-bound IL1Rs on subpopulations of mononuclear cells or serum levels of soluble IL-1 receptors. It was observed that healthy individuals with the genotype TT in SNP rs2234650:C.T had a lower percentage of intact CD14
INTRODUCTION
Interleukin-1 (IL-1) is a cytokine involved in a wide range of physiological processes, including having a central role in the regulation of acute and chronic inflammation. 1, 2 The biological effects of IL-1 (IL-1a and IL-1b) are achieved by the binding of the cytokine to the membrane-bound IL-1 type 1 receptor (IL1R1). 3, 4 IL1R1 is a glycoprotein with a molecular mass of 80 kDa that is predominantly expressed on endothelial cells, smooth muscle cells, epithelial cells, hepatocytes, fibroblasts, keratinocytes, epidermal dendritic cells and T lymphocytes. 5 IL-1 binding to the extracellular domain of IL1R1 promotes the recruitment of the IL-1 receptor accessory protein, which leads to signal transduction mediated by the cytoplasmic domains of IL1R1 and IL1R2 receptors. 6 The IL-1 type 2 receptor (IL1R2) is unable to initiate signaling and only acts as a 'decoy' receptor. 3, 7 IL1R2 is a glycoprotein with a molecular mass of 60 kDa that is expressed on monocytes, neutrophils, T and B lymphocytes. 8, 9 Studies have also provided evidence for the existence of soluble receptors for IL-1 (sIL1Rs), 10, 11 which are derived via proteolytic cleavage of membrane-bound receptors 12 or by alternative splicing. 13 The sIL1Rs act as natural inhibitors of IL-1 activity by preventing the interaction between IL-1 and membrane-bound IL1Rs. 6, 14 The IL1R1 and IL1R2 genes are located on the long arm of chromosome 2 (2q12-13) and both appear to be driven by multiple promoters. The IL1R1 gene has three distinct promoters which have no TATA or CAAT box motifs and belong to a group of housekeeping gene promoters. These three promoters (referred to as exons 1A, 1B and 1C) generate transcripts with different 59-untranslated regions. 15, 16 It is known that the expression of cytokines and their receptors can be influenced by genetic polymorphisms. 19, 20 Furthermore, polymorphisms in the regulatory regions of cytokines genes can also alter mRNA splicing, mRNA stability and the level of gene transcription. 17, 18 Functional cellular responses to cytokines depend on the expression level of the specific receptors. It is therefore important to know not only the percentage of cells expressing these membrane-bound receptors but also the density of these receptors on the cells. 21, 22 Differing expression levels of IL-1 receptors type 1 and 2 have previously been shown in T-lymphocyte populations. 23 Moreover, prior studies have examined the association of polymorphisms in the IL-1 receptor genes with different diseases. However, data on association of these polymorphisms with receptor protein expression levels have not yet been published.
The aim of this study was to determine if there is an association between polymorphisms in the IL-1 type 1and type 2 receptor genes and the expression levels of these membranebound receptors on different subpopulations of mononuclear cells. We also examined the serum levels of sIL1Rs in healthy individuals.
MATERIAL AND METHODS

Blood samples
Blood samples were obtained from Blood Procurement Station No. 1 at the Novosibirsk Blood Center and collected in sterile VACUETTE ethylenediaminetetraacetic acid and serum clot activator tubes (Greiner Bio-One, Kremsmünster, Austria). Samples (n5150) were obtained from individuals from Novosibirsk (Western Siberia, Russia) and included 83 males and 67 females between the ages of 19 and 55 years (mean: 3461 years). Inclusion in the study required that all individuals belong to the Russian ethnic group, were healthy and unrelated. The main exclusion criteria were those standard for blood donors in the Russian Federation: age (,18, .60 years of age), body weight (,50 kg), blood pressure (systolic ,90, .160 mmHg; diastolic ,60, .100 mmHg), body temperature (.37 uC), pulse (,50, .100 BPM), diseases (URTI, quinsy, flu, virus hepatitis, tuberculosis, brucellosis, typhus, tularemia, leprosy, HIV, syphilis, oncological diseases), allergy, drug treatment (antibiotics, analgesics), pregnancy and lactation periods. Research was performed in accordance with the Declaration of Helsinki and was approved by the local ethics committee of the FSBI 'Research Institute of Clinical Immunology'. All individuals provided informed consent before the study was performed.
Isolation of mononuclear cells and stimulation conditions
Peripheral blood mononuclear cells (PBMCs) were isolated from peripheral blood according to standard methods using a Ficoll-Urografin density gradient (r51.077 g/cm 3 ). 24 The isolated PBMCs were cultured in RPMI-1640 medium containing 10% fetal calf serum, 2 mM L-glutamine, 10 mM HEPES buffer, 0.5 mm 2-mercaptoethanol, 80 mg/ml gentamicin and 100 mg/ml benzylpenicillin for 24 h under 5% SO 2 at 37 uS. The cells were cultured at a concentration of 2310 6 25 Determination of serum levels of soluble IL1 type 1 and 2 receptors Serum levels of soluble IL-1 type 1 and 2 receptors were determined via enzyme-linked immunosorbent assay (ELISA) using the Human IL1sR1 ELISA and Human IL1sR2 ELISA kits (RayBiotech, Norcross, GA, USA) according to the manufacturer's instructions. The sensitivity of the assays was 6 pg/ml (sIL1R1) and 5 pg/ml (sIL1R2).
Genotyping methods single nucleotide polymorphisms (SNPs) located within IL1R1 and IL1R2 genes were selected from the SNP database at the National Center for Biotechnology Information (http:// www.ncbi.nlm.nih.gov/snp). Specific SNPs were chosen for study using the following criteria: (i) location within the promoter region of the IL1R1 and IL1R2 genes; (ii) high frequency of minor allele expression (.10%); and (iii) potential for association with pathological states.
Genomic DNA was isolated by phenol-chloroform extraction. 26 Genotyping was performed using restriction fragment length polymorphism analysis of polymerase chain reaction (PCR)-amplified fragments. Primer sequences for SNP IL1R1 rs2234650:C.T have been described previously. 27 Primers for SNP IL1R1 rs3917225:A.G, IL1R2 rs4141134:T.C and IL1R2 rs2071008:T.G were designed using NCBI/Primer-BLAST (http://www.ncbi.nlm.nih.gov/tools/primer-blast). Primers (Table 1) were synthesized by BIOSAN (Novosibirsk, Russia).
PCR was performed using a PTC-200 DNA thermocycler (MJ Research Inc., Watertown, MA, USA). The 20 ml reaction volume contained 1-2 units Taq DNA polymerase (SibEnzyme, Novosibirsk, Russia), 0.5 mM of each primer, 0.25 mM of each deoxyribonucleotide-triphosphate and 50-200 ng of genomic DNA. The reaction buffer added to the DNA polymerase contained 60 mM Tris-HCl (pH 8.5, 25 uC), 1.5 mM MgCl 2 , 25 mM KCl, 10 mM 2-mercaptoethanol and 0.1% Triton X-100. PCR conditions were as follows: initial denaturation for 3 min at 95 uC; followed by 30 cycles (rs3917225:A.G, rs2234650:C.T, and rs2071008:T.G) or 38 cycles (rs4141134:T.C) as follows: denaturation at 94 uC for 20 s; annealing at 57 uC for 15 s (rs3917225:A.G); 70 uC for 15 s (rs2234650:C.T); 60 uC for 15 s (rs4141134:T.C); and 58 uC for 15 s (rs2071008:T.G); extension at 72 uC for 20 s, with a final extension at 72 uC for 2 min.
PCR products were incubated with restriction enzymes from SibEnzyme (Table 1 ) at 37 uC. Restriction products were analyzed by electrophoresis of 2% agarose (Medigen, Novosibirsk, Russia) in Tris-acetate-ethylenediaminetetraacetic acid buffer. The pUC19 plasmid digested with Msp I served as a molecular weight marker (SibEnzyme). Restriction products were visualized under ultraviolet light and the molecular weights of fragments were evaluated with the aid of a Videodensitometer ImageMaster VDS (Pharmacia Biotech, Uppsala, Sweden).
Statistical analysis
Statistical analysis was performed using the software STATISTICA 7.0 (StatSoft Inc. Moscow, Russia). Compliance of genotype frequency distributions with the Hardy-Weinberg equilibrium was established by the x 2 test (online calculator provided by Tufts University, Boston, MA, USA (http://www.tufts.edu/,mcourt01/ Documents/Court%200l lab%20-%20HW%20calculator.xls)).
Data were tested for normality by the Shapiro-Wilk's W test and the Kolmogorov-Smirnov Z test. The hypothesis that the respective distribution was normal was rejected in most cases. More stringent non-parametric tests were used for subsequent analysis and all data were expressed as median values with quartiles. Correlation analysis was performed using Spearman's rank correlation. Comparison of all sample values and the determination of genotypic relationships with protein expression levels were performed using the Kruskal-Wallis H test, and the examination between the medians using the Mann-Whitney U test. All differences were considered significant at Pf0.05. After performing Bonferroni's correction for the pairwise comparisons of genotypes, P-values ,0.017 were considered to indicate statistical significance.
RESULTS
Expression levels of membrane-bound IL1 type 1 and 2 receptors on subpopulations of mononuclear cells Expression levels of membrane-bound IL-1 type 1 and 2 receptors on subpopulations of mononuclear cells are shown in Table 2 . In each subpopulation of mononuclear cells (CD3 The number of membrane-bound IL1Rs per cell was determined using Quantibrite PE Calibration Beads, and the least average amounts of IL1R1s and IL1R2s were determined for SD14
1 monocytes and CD3 1 T lymphocytes (P,0.001), respectively. CD3
1 T lymphocytes and CD19 1 B lymphocytes showed higher levels of IL1R1 per cell than IL1R2 (P,0.001), while in SD14
1 monocytes, the number of IL1R2s per cell was greater than the number of IL1R1s (P,0.05).
The comparison of IL1R expression levels on SD14 1 monocytes in unstimulated versus LPS-stimulated PBMC revealed a significant increase in both the percentage of cells expressing IL1R1 and the absolute number of IL1R1s molecules in response to mitogen stimulation (P,0.001). In addition, a significant decrease in the percentage of cells expressing IL1R2 and a decrease in the absolute number of receptors were observed in response to LPS activation (P,0.05). Statistically significant differences (P,0.001) were also observed for the percentage of IL1R
1 cells and the absolute number of these receptors on cells in both the total intact CD14 1 cell populations and the CD14 1 cells from the unstimulated PBMC culture.
Serum levels of sIL1 type 1 and 2 receptors The serum levels of sIL1R1 and sIL1R2 were also examined ( Figure 1) . Overall, the serum levels of sIL1R2 were significantly higher than sIL1R1 (P,0.001), but there was no correlation between sIL1R1 and sIL1R2 levels.
Association of SNPs rs3917225:A.G and rs2234650:C.T in the promoter region of the IL1R1 gene with IL-1R expression levels The genotypes and allele frequencies of SNPs in the promoter regions of the IL1R1 (rs3917225:A.G, rs2234650:C.T) and IL1R2 (rs4141134:T.C, rs2071008:T.G) genes in healthy individuals from Novosibirsk (Western Siberia, Russia) are shown in Table 3 . The genotypes and allele frequencies of all four examined polymorphisms corresponded with the Hardy-Weinberg equilibrium (HWE) (P.0.05). No statistically significant differences were found in genotypes and allele frequencies between groups of men and women.
There was no statistically significant relationship between the SNPs rs3917225:A. Figure 5 ). The frequency of the GG genotype was extremely low (2.1%); therefore, the above analysis was not able to be carried out in this group.
DISCUSSION
In this study, we examined the expression of membrane-bound IL-1 type 1 and 2 receptors on different subpopulations of mononuclear cells from the peripheral blood of healthy individuals. We have demonstrated quantitative differences in expression levels, both in the percentage of cells carrying the receptors, and in the absolute number of these receptors expressed on the surface of CD3 1 T lymphocytes, CD19 1 B lymphocytes and CD14 1 monocytes. It is known that IL1R1 (as opposed to the 'decoy' receptor IL1R2) is capable of promoting the signal transduction that leads to its effector functions. Thus, it is possible that the functional response of a cell population to IL-1 may depend on the balance between the levels of IL1R1 and IL1R2 on the cells. 
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1 and CD14 1 subpopulations. Therefore, the percentage of receptor positive cells and the expression density of these receptors on individual cells are not always related.
This study also investigated changes in the expression levels of IL1R1 and IL1R2 as a result of LPS stimulation. Saccani et al. 28 and Penton-Rol et al. 29 found that incubating cells in presence of LPS led to an increase in IL1R1 mRNA levels and a decrease in IL1R2 mRNA levels. Our data examining the changes in protein levels are consistent with these previous studies and reflective of those changes in mRNA levels during cell stimulation. A reproducible increase in the percentage of IL1R1 1 cells and in the absolute amount of IL1R1 molecules was observed when we compared the expression of IL1R1 on CD14 1 monocytes from unstimulated versus LPS-stimulated PBMC cultures. Analysis of IL-1 type 2 receptor expression after LPS stimulation also has revealed a decrease in the percentage of IL1R2 1 cells and a decrease in the average number of IL1R2s on CD14 1 cells. When we compared IL1R1 and IL1R2 expression between intact CD14
1 monocytes with CD14 1 monocytes that had been cultivated for 24 h, we observed a similar increase in the number of IL1R1s and IL1R2s by approximately 600 receptors. Thereby, a decrease in the percentage of IL1R1 1 cells and an increase in the percentage of IL1R2 1 cells occurred, suggesting that these changes in the expression levels of the IL1Rs were due to changes in the culture microenvironment.
Therefore, we demonstrated differences in the expression levels of membrane-bound IL-1 type 1I and 2II receptors on immunocompetent cells. It is known that differences in expression of cytokine receptors can be caused by gene polymorphisms. 20, 22 Polymorphisms in cytokine genes and their receptors have been the focus of intensive investigations for the last 15 years. Prior studies have found associations of specific polymorphisms with the predisposition to certain diseases, with their clinical course and outcome, as well as with appropriate therapies. 30, 31 Polymorphisms within the promoter regions of genes may directly influence the structure of transcription factor binding sites and mRNA stability, 17, 18 thereby leading to differences in protein expression.
A number of studies have been performed to examine the role of the SNP rs3917225:A.G in the IL1R1 gene. Nakki et al. 32 showed that the A allele is associated with severe hand osteoarthritis. Park et al. 33 found that the rs3917225:A.G polymorphism did not associated with papillary thyroid carcinoma. One of the most investigated polymorphisms in the IL1R1 gene is the SNP rs2234650:C.T (also known as 1970 C/ T PstI). Previous has shown an association of the T allele of SNP rs2234650:C.T with diabetes mellitus type I, 34 AIDS progression 35 and the C allele has been associated with asthma. 36 It is known that the activity of specific mediators (i.e., cytokines) depends on the density of their receptor on cells. 21, 22 Thus, it may be assumed that individuals with the above SNP genotypes in the IL1R1 gene may be more susceptible to the action of IL-1 due to their increased expression of the signal transductioncapable IL-1 type 1 receptors. Our study demonstrated that individuals with the homozygous TT genotype in SNP rs2234650:C.T in the IL1R1 gene have a lower percentage of cells expressing IL1R1 on the intact CD14 1 monocyte population. These data provide evidence that the T allele is associated with lower expression of membrane-bound IL1R1s on populations of CD14 1 cells. Thus, it may be assumed that the population of monocytes in individuals with the TT genotype may have a lowered functional response to IL-1 mediators. However, these assumptions will require direct experimental confirmation.
Polymorphisms in the IL1R2 gene are not well understood. We examined two polymorphisms (SNPs rs4141134:T.C and rs2071008:T.G) in the promoter region of the IL1R2 gene. Individuals with the CC genotype in SNP rs4141134:T.C showed an increase in the percentage of CD3 1 T cells expressing membrane-bound IL1R2. The percentage of cells carrying specific surface receptors may predetermine the potential reaction to certain mediators. It is likely that the biological effects of a given mediator may be stronger in a population of cells carrying increased percentage of the mediator's receptor. In this case, however, the higher percentage of IL1R2 1 cells exerts the reverse effect, i.e., blocking signal transduction by competing with IL1R1 for binding of the mediator (IL-1). 37 Thus, an increase in the percentage of cells expressing the 'decoy' receptor, IL1R2, limits the functional effect of IL-1 in these subpopulations.
The individuals with the CC genotype in SNP rs4141134:T.C and the TT genotype in SNP rs2071008:T.G have lower levels of membrane-bound IL1R2 on CD14 1 cells isolated from LPS-stimulated PBMC cultures. It is well known that LPS activates the release of the IL-1 cytokine. 38 Hence, it may be expected that those individuals homozygous for the C allele in rs4141134:T.C and the T allele in rs2071008:T.G individuals should show stronger effects in response to LPS stimulation, as they have a lower number of 'decoy' IL1R2 receptors on the surface of CD14 1 monocytes. Most likely the T allele in IL1R2 rs4141134: T.C has the greater potential for stimulation of IL-1 type 2 receptor expression.
The modification of binding sites for transcription factors is the most possible mechanism linking SNPs and gene expression activity. The AliBaba2.1 software was used to examine the potential for transcription factors to bind to specific allele sequences (http://www.gene-regulation.com/pub/programs/alibaba2/ index.html). The presence of the G allele in SNPs rs3917225:A.G and rs2071008:T.G presents possible binding sites for transcription factors Pit-1a and TAF-1, respectively. TAF1 (RNA polymerase II, TATA box binding protein-associated factor, 250 kDa) is an essential protein required for progression of the cell cycle and repression of apoptosis in mammalian cells. 39 The TAF1 has intrinsic protein kinase activity, 40 histone acetyltransferase activity 41 and ubiquitin-activating activity (E1/ E2).
42 TAF1 binds to and modulates the transcriptional activity of proteins such as c-Jun, 43 Mdm2 44 and cyclin D1 45 and, therefore, participates in cancer progression.
The presence of the C allele in SNP rs2234650 provides the ability to bind the transcription factor Yin Yang 1, whereas the T allele sequence can bind the transcription factor activating protein 1. Yin Yang 1 is a ubiquitous and multifunctional zinc-finger transcription factor that interacts with histone acetyltransferases and deacetylases for its transcriptional activity and is also involved in inflammation and tumorigenesis. 46 Yin Yang 1has been shown to enhance the cyclooxygenase-2 protein expression and prostaglandin D2 production elicited by LPS treatment. 47 Activating protein 1 is a dimeric transcription factor, implicated in the regulation of a variety of cellular processes including proliferation and survival, differentiation, growth, inflammation, apoptosis, cell migration and transformation. 48 It is possible that the differences in IL1R expression are due to changes in the binding of these transcription factors. However, the involvement of these transcription factors in the regulation of IL1R genes expression requires direct experimental confirmation at the level of mRNA and protein synthesis.
There are some potential limitations to this study. The sample size was relatively small and collected from a homogeneous ethnic group. Gene expression was tested at the protein level, but mRNA levels not were assessed. Furthermore, only a limited number of SNPs were investigated. However, the presented results provide a basis for further study of the functionality these polymorphisms and potential molecular mechanisms of the revealed associations.
CONCLUSION
This study has shown quantitative differences in the expression levels of membrane-bound IL-1 type 1 and 2 receptors on subpopulations of immunocompetent cells from healthy individuals. Moreover, differences in the expression levels of two types of membrane-bound IL1Rs on cells cultivated in the presence of the polyclonal activator LPS were estimated. Furthermore, it was established that differences in the expression of the IL1Rs may be related to single nucleotide polymorphisms in promoter regions of these genes. Therefore, polymorphisms of the IL1R genes may be one of the factors influencing the level of expression of membrane-bound IL1Rs on PBMC.
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